Clinical Trial: Vascular/Surgical - PATENCY-2

Overview

PATENCY-2 

Multicenter, Double-Blind, Placebo-Controlled Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease

Objective

This research study is enrolling patients with chronic kidney disease from Lake Washington Vascular who will undergo a Radiocephalic Arteriovenous Fistula creation to create a new access to their bloodstream for hemodialysis. This study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase.

Study Coordinator(s)

Krissa Gunderson, CRC: 425.732.5958, krissag@lkwv.com

Irina Stipek, CRC: 425.732.5959, irinas@lkwv.com

Complete the online contact information form. 

Learn More

• ClinicalTrials.gov

Clinical Trial Categories

Vascular/Surgical